Skip navigation



AMSBIO has Introduced New Powerful CRISPR/Cas9 Gene Editing Kits

AMSBIO has introduced new CRISPR / Cas9 editing kits for gene knock-out, gene knock-in and gene mutation applications. More »
18 July 2018

Silence Therapeutics Appoints David Horn Solomon as Chief Executive Officer

Silence Therapeutics plc, AIM:SLN (“Silence” or “the Company”) a leader in the discovery and development of novel RNA therapeutics announces today the appointment of Dr David Horn Solomon as its new Chief Executive Officer (CEO) effective immediately. David will head the Leadership Team and joins the Board of Directors. More »
18 July 2018

Wickham Laboratories Announce Latest Article on Sterility Testing Environments and the Vital Role of Isolators

Wickham Laboratories is pleased to announce our latest article published by Cleanroom Technology, “Isolator sterility put to the test,” written by our Sterility Section Head, Stacey Orley. More »
16 July 2018

One Nucleus Recruit New Video Partner

One Nucleus, Europe’s largest membership organisation for companies working within the Life Science and Healthcare industry has added Giggabox to its Partner Programme. Giggabox will play an influential and visible role in the development of the One Nucleus life science community by crafting explainer videos and developing corporate films for members at preferential rates. More »
12 July 2018

PiR’s Diversity Report Findings

“Females are likely to be the highest earner in their household”; this is one of the findings from PiR’s recent Diversity Survey for senior executives in the life science industry. PiR commissioned the Survey to identify if there is any disparity of reward focused around gender within the life science sector. More »
09 July 2018

Abingworth Raises $315m for ABV VII

Abingworth, the international investment group dedicated to life sciences, today announced the final closing of its latest fund, Abingworth Bioventures VII (ABV VII) at $315 million. More »
09 July 2018

BioIVT Acquires Optivia Biotechnology, Adding Transporter Assay Products and Services to its ADME-Tox Portfolio

Acquisition strengthens BioIVT’s transporter sciences capabilities and enables it to partner with customers on new drug applications and mechanistic studies related to transporters. More »
09 July 2018

AMSBIO Launch New Screening Company

ScreenIn3D (Glasgow, UK) is a new joint venture company set up by AMSBIO and the University of Strathclyde exploiting the latest advances in microfluidics and 3D culture to develop a novel microfluidic screening platform. More »
05 July 2018

Accelerate@Babraham Start-up Competition: Short-listed Finalists Announced

Eight life science start-ups will pitch head-to-head on 11th July to win access to the Babraham Research Campus bio-incubator facilities, Accelerate@Babraham More »
04 July 2018

Concept Life Sciences Appoints John Vu as West Coast Business Development Director

Concept Life Sciences (Concept), the integrated drug discovery, development and analytical services company, today announced it has appointed John Vu as Business Development Director for the West Coast, to further expand the group’s presence in and support for the US market. More »
04 July 2018

<< Previous   Page 1 of 43   Next >>